[ad_1] 1 / 14 Biocon | Biotechnology firm said its wholly-owned subsidiary, Biocon Pharma Ltd, has received final approvals from the US Food and Drug Administration (FDA) for its abbreviated new drug applications (ANDAs). Lenalidomide capsules, in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg strengths. Lenalidomide is a medication […]
Headline
Tag: Welspun Specialty Solutions share price
Back To Top